Search Results 841-850 of 14717 for anti-TNF drugs

  1. Decongestant And Analgesic Combinations (Oral Route) Before Using - Mayo Clinic

    Allergies. Tell your doctor if you have ever had any unusual or allergic reaction to medicines in this group or any other medicines. Also tell your health care ...

  2. Emtricitabine And Tenofovir (Oral Route) Description and Brand Names - Mayo Clinic

    Emtricitabine and tenofovir disoproxil fumarate combination is used together with other medicines to treat human immunodeficiency virus (HIV) infection. HIV is ...

  3. Sleep aids: Understand options sold without a prescription - Mayo Clinic

    Alcohol can increase the sedative effects of the medication. Beware of side effects. Don't drive or attempt other activities that require alertness while taking ...

  4. Antivenin (Crotalidae) Polyvalent (Injection Route) Side Effects - Mayo Clinic

    The severity of the symptoms and the length of the sickness depend on the amount of pit viper antivenin you were given and how long the treatment lasted. During ...

  5. Glyburide, Micronized (Oral Route) Before Using - Mayo Clinic

    Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

  6. Carboplatin and Paclitaxel With or Without Atezolizumab Before Surgery in Treating Patients With Newly Diagnosed, Stage II-III Triple-Negative Breast Cancer - Mayo Clinic

    Drugs used in chemotherapy ... TNF] agents) within 2 weeks prior to cycle 1, day 1: ... A stable regimen of highly active anti-retroviral therapy (HAART); ...

  7. Combination Chemotherapy and Pralatrexate as First-Line Therapy in Treating Patients With Non-Hodgkin Lymphoma - Mayo Clinic

    About this study. This phase II trial studies how well combination chemotherapy and pralatrexate works in treating patients with non-Hodgkin lymphoma (NHL).

  8. Brexucabtagene Autoleucel (Intravenous Route) Description and Brand Names - Mayo Clinic

    Before you begin treatment, talk to your doctor about the benefits of this medicine as well as the possible risks of receiving it. This medicine is available ...

  9. A Study of the Safety and Drug/Body Interactions of LAM-002A for Patients with Non-Hodgkin's Lymphoma - Mayo Clinic

    The purpose of this study is to evaluate the safety, tolerability, drug/body interactions, and preliminary activity of LAM-002A for the treatment of patients ...

  10. Why gastroenterologists and hepatologists should be involved in treating obesity - Mayo Clinic

    Research has shown us that obesity increases likelihood of nonresponse to treatment with tumor necrosis factor α (TNFα) inhibitors, a staple in the treatment of ...